Proteïna ADNP (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Proteïna ADNP" in Catalan language version.

refsWebsite

Global rank Catalan rank

14doi.org

2^nd place

6^th place

14nih.gov

4^th place

7^th place

10worldcat.org

5^th place

2elsevier.com

610^th place

253^rd place

1medlineplus.gov

1,581^st place

1,158^th place

1wiley.com

222^nd place

128^th place

1mdpi.com

2,912^th place

991^st place

1nature.com

234^th place

127^th place

1rarediseases.org

5,181^st place

low place

1biomedcentral.com

2,747^th place

771^st place

biomedcentral.com

bmcmedgenomics.biomedcentral.com

Wang, X.; Peng, H.; Zhang, G. et al. «ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis». BMC Medical Genomics, 16, 1, 31-07-2023. DOI: 10.1186/s12920-023-01592-x. ISSN: 1755-8794. PMC: PMC10391866. PMID: 37525242.

doi.org

dx.doi.org

Bassan, M.; Zamostiano, R.; Davidson, A. et al. «Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide». Journal of Neurochemistry, 72, 3, 07-07-2008, pàg. 1283–1293. DOI: 10.1046/j.1471-4159.1999.0721283.x.
Wu, J. Y.; Henins, K. A.; Gressens, P. et al «Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period». Peptides, 18, 8, 1997, pàg. 1131–1137. DOI: 10.1016/s0196-9781(97)00146-0. ISSN: 0196-9781. PMID: 9396053.
Gozes, I.; Zamostiano, R.; Pinhasov, A. et al. «A Novel VIP Responsive Gene: Activity Dependent Neuroprotective Protein». Annals of the New York Academy of Sciences, 921, 1, 12-2000, pàg. 115–118. DOI: 10.1111/j.1749-6632.2000.tb06957.x. ISSN: 0077-8923.
Zamostiano, R.; Pinhasov, A.; Gelber, E. et al. «Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein». Journal of Biological Chemistry, 276, 1, 1-2001, pàg. 708–714. DOI: 10.1074/jbc.M007416200.
Shain, A. H.; Pollack, J. R. «The spectrum of SWI/SNF mutations, ubiquitous in human cancers». PloS One, 8, 1, 2013, pàg. e55119. DOI: 10.1371/journal.pone.0055119. ISSN: 1932-6203. PMC: 3552954. PMID: 23355908.
Sun, X.; Peng, X.; Cao, Y. et al. «ADNP promotes neural differentiation by modulating Wnt/β-catenin signaling». Nature Communications, 11, 1, 12-06-2020, pàg. 2984. DOI: 10.1038/s41467-020-16799-0. ISSN: 2041-1723. PMC: 7293280. PMID: 32533114.
Giladi, E.; Hill, J. M.; Dresner, E. et al. «Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo». Journal of molecular neuroscience: MN, 33, 3, 2007, pàg. 278–283. DOI: 10.1007/s12031-007-9003-0. ISSN: 0895-8696. PMID: 17952637.
Maugeri, G.; D’Amico, A. G.; Magrì, B. «Activity-Dependent Neuroprotective Protein (ADNP): An Overview of Its Role in the Eye». International Journal of Molecular Sciences, 23, 21, 1-2022, pàg. 13654. DOI: 10.3390/ijms232113654. ISSN: 1422-0067.
Tuszynski, M. H.; Thal, L.; Pay, M. et al. «A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease». Nature Medicine, 11, 5, 5-2005, pàg. 551–555. DOI: 10.1038/nm1239. ISSN: 1546-170X.
D’Incal, C. P.; Van Rossem, K. E.; De Man, K. et al. «Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism». Clinical Epigenetics, 15, 1, 21-03-2023, pàg. 45. DOI: 10.1186/s13148-023-01450-8. ISSN: 1868-7083. PMC: PMC10031977. PMID: 36945042.
Lord, C.; Elsabbagh, M.; Baird, G. et al. «Autism spectrum disorder». Lancet (London, England), 392, 10146, 11-08-2018, pàg. 508–520. DOI: 10.1016/S0140-6736(18)31129-2. ISSN: 1474-547X. PMC: 7398158. PMID: 30078460.
Karagoz, K.; Mehta, G. A.; Khella, C. A. et al. «Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis». EBioMedicine, 50, 12-2019, pàg. 191–202. DOI: 10.1016/j.ebiom.2019.11.009. PMC: PMC6921307. PMID: 31767542.
Wang, X.; Peng, H.; Zhang, G. et al. «ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis». BMC Medical Genomics, 16, 1, 31-07-2023. DOI: 10.1186/s12920-023-01592-x. ISSN: 1755-8794. PMC: PMC10391866. PMID: 37525242.

doi.org

D’Incal, C. P.; Van Rossem, K. E.; De Man, K. et al. «Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism». Clinical Epigenetics, 15, 1, 21-03-2023, pàg. 45. DOI: 10.1186/s13148-023-01450-8. ISSN: 1868-7083. PMC: PMC10031977. PMID: 36945042.

elsevier.com

linkinghub.elsevier.com

Zamostiano, R.; Pinhasov, A.; Gelber, E. et al. «Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein». Journal of Biological Chemistry, 276, 1, 1-2001, pàg. 708–714. DOI: 10.1074/jbc.M007416200.
Karagoz, K.; Mehta, G. A.; Khella, C. A. et al. «Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis». EBioMedicine, 50, 12-2019, pàg. 191–202. DOI: 10.1016/j.ebiom.2019.11.009. PMC: PMC6921307. PMID: 31767542.

mdpi.com

Maugeri, G.; D’Amico, A. G.; Magrì, B. «Activity-Dependent Neuroprotective Protein (ADNP): An Overview of Its Role in the Eye». International Journal of Molecular Sciences, 23, 21, 1-2022, pàg. 13654. DOI: 10.3390/ijms232113654. ISSN: 1422-0067.

medlineplus.gov

«ADNP gene: MedlinePlus Genetics». [Consulta: 18 octubre 2023].

nature.com

Tuszynski, M. H.; Thal, L.; Pay, M. et al. «A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease». Nature Medicine, 11, 5, 5-2005, pàg. 551–555. DOI: 10.1038/nm1239. ISSN: 1546-170X.

nih.gov

ncbi.nlm.nih.gov

Wu, J. Y.; Henins, K. A.; Gressens, P. et al «Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period». Peptides, 18, 8, 1997, pàg. 1131–1137. DOI: 10.1016/s0196-9781(97)00146-0. ISSN: 0196-9781. PMID: 9396053.
Shain, A. H.; Pollack, J. R. «The spectrum of SWI/SNF mutations, ubiquitous in human cancers». PloS One, 8, 1, 2013, pàg. e55119. DOI: 10.1371/journal.pone.0055119. ISSN: 1932-6203. PMC: 3552954. PMID: 23355908.
Sun, X.; Peng, X.; Cao, Y. et al. «ADNP promotes neural differentiation by modulating Wnt/β-catenin signaling». Nature Communications, 11, 1, 12-06-2020, pàg. 2984. DOI: 10.1038/s41467-020-16799-0. ISSN: 2041-1723. PMC: 7293280. PMID: 32533114.
Giladi, E.; Hill, J. M.; Dresner, E. et al. «Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo». Journal of molecular neuroscience: MN, 33, 3, 2007, pàg. 278–283. DOI: 10.1007/s12031-007-9003-0. ISSN: 0895-8696. PMID: 17952637.
D’Incal, C. P.; Van Rossem, K. E.; De Man, K. et al. «Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism». Clinical Epigenetics, 15, 1, 21-03-2023, pàg. 45. DOI: 10.1186/s13148-023-01450-8. ISSN: 1868-7083. PMC: PMC10031977. PMID: 36945042.
Van Dijck, A.; Vandeweyer, G.; Kooy, F. ADNP-Related Disorder. Seattle (WA): University of Washington, Seattle, 07-04-2016.
Lord, C.; Elsabbagh, M.; Baird, G. et al. «Autism spectrum disorder». Lancet (London, England), 392, 10146, 11-08-2018, pàg. 508–520. DOI: 10.1016/S0140-6736(18)31129-2. ISSN: 1474-547X. PMC: 7398158. PMID: 30078460.
Karagoz, K.; Mehta, G. A.; Khella, C. A. et al. «Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis». EBioMedicine, 50, 12-2019, pàg. 191–202. DOI: 10.1016/j.ebiom.2019.11.009. PMC: PMC6921307. PMID: 31767542.
Wang, X.; Peng, H.; Zhang, G. et al. «ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis». BMC Medical Genomics, 16, 1, 31-07-2023. DOI: 10.1186/s12920-023-01592-x. ISSN: 1755-8794. PMC: PMC10391866. PMID: 37525242.

pubmed.ncbi.nlm.nih.gov

Wu, J. Y.; Henins, K. A.; Gressens, P. et al «Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period». Peptides, 18, 8, 1997, pàg. 1131–1137. DOI: 10.1016/s0196-9781(97)00146-0. ISSN: 0196-9781. PMID: 9396053.
Shain, A. H.; Pollack, J. R. «The spectrum of SWI/SNF mutations, ubiquitous in human cancers». PloS One, 8, 1, 2013, pàg. e55119. DOI: 10.1371/journal.pone.0055119. ISSN: 1932-6203. PMC: 3552954. PMID: 23355908.
Sun, X.; Peng, X.; Cao, Y. et al. «ADNP promotes neural differentiation by modulating Wnt/β-catenin signaling». Nature Communications, 11, 1, 12-06-2020, pàg. 2984. DOI: 10.1038/s41467-020-16799-0. ISSN: 2041-1723. PMC: 7293280. PMID: 32533114.
Giladi, E.; Hill, J. M.; Dresner, E. et al. «Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo». Journal of molecular neuroscience: MN, 33, 3, 2007, pàg. 278–283. DOI: 10.1007/s12031-007-9003-0. ISSN: 0895-8696. PMID: 17952637.
Lord, C.; Elsabbagh, M.; Baird, G. et al. «Autism spectrum disorder». Lancet (London, England), 392, 10146, 11-08-2018, pàg. 508–520. DOI: 10.1016/S0140-6736(18)31129-2. ISSN: 1474-547X. PMC: 7398158. PMID: 30078460.

rarediseases.org

«ADNP Syndrome - Symptoms, Causes, Treatment | NORD». [Consulta: 13 octubre 2023].

wiley.com

doi.wiley.com

Bassan, M.; Zamostiano, R.; Davidson, A. et al. «Complete Sequence of a Novel Protein Containing a Femtomolar-Activity-Dependent Neuroprotective Peptide». Journal of Neurochemistry, 72, 3, 07-07-2008, pàg. 1283–1293. DOI: 10.1046/j.1471-4159.1999.0721283.x.

worldcat.org

Wu, J. Y.; Henins, K. A.; Gressens, P. et al «Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period». Peptides, 18, 8, 1997, pàg. 1131–1137. DOI: 10.1016/s0196-9781(97)00146-0. ISSN: 0196-9781. PMID: 9396053.
Gozes, I.; Zamostiano, R.; Pinhasov, A. et al. «A Novel VIP Responsive Gene: Activity Dependent Neuroprotective Protein». Annals of the New York Academy of Sciences, 921, 1, 12-2000, pàg. 115–118. DOI: 10.1111/j.1749-6632.2000.tb06957.x. ISSN: 0077-8923.
Shain, A. H.; Pollack, J. R. «The spectrum of SWI/SNF mutations, ubiquitous in human cancers». PloS One, 8, 1, 2013, pàg. e55119. DOI: 10.1371/journal.pone.0055119. ISSN: 1932-6203. PMC: 3552954. PMID: 23355908.
Sun, X.; Peng, X.; Cao, Y. et al. «ADNP promotes neural differentiation by modulating Wnt/β-catenin signaling». Nature Communications, 11, 1, 12-06-2020, pàg. 2984. DOI: 10.1038/s41467-020-16799-0. ISSN: 2041-1723. PMC: 7293280. PMID: 32533114.
Giladi, E.; Hill, J. M.; Dresner, E. et al. «Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo». Journal of molecular neuroscience: MN, 33, 3, 2007, pàg. 278–283. DOI: 10.1007/s12031-007-9003-0. ISSN: 0895-8696. PMID: 17952637.
Maugeri, G.; D’Amico, A. G.; Magrì, B. «Activity-Dependent Neuroprotective Protein (ADNP): An Overview of Its Role in the Eye». International Journal of Molecular Sciences, 23, 21, 1-2022, pàg. 13654. DOI: 10.3390/ijms232113654. ISSN: 1422-0067.
Tuszynski, M. H.; Thal, L.; Pay, M. et al. «A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease». Nature Medicine, 11, 5, 5-2005, pàg. 551–555. DOI: 10.1038/nm1239. ISSN: 1546-170X.
D’Incal, C. P.; Van Rossem, K. E.; De Man, K. et al. «Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism». Clinical Epigenetics, 15, 1, 21-03-2023, pàg. 45. DOI: 10.1186/s13148-023-01450-8. ISSN: 1868-7083. PMC: PMC10031977. PMID: 36945042.
Lord, C.; Elsabbagh, M.; Baird, G. et al. «Autism spectrum disorder». Lancet (London, England), 392, 10146, 11-08-2018, pàg. 508–520. DOI: 10.1016/S0140-6736(18)31129-2. ISSN: 1474-547X. PMC: 7398158. PMID: 30078460.
Wang, X.; Peng, H.; Zhang, G. et al. «ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis». BMC Medical Genomics, 16, 1, 31-07-2023. DOI: 10.1186/s12920-023-01592-x. ISSN: 1755-8794. PMC: PMC10391866. PMID: 37525242.